SYLMAR, Calif.—Second Sight Medical Products (NASDAQ:EYES) has appointed Will McGuire, a 20-year veteran of the life sciences industry, as president and chief executive officer, effective Aug. 18, 2015. He succeeds Robert Greenberg, MD, PhD, who will become chairman of the board of directors of Second Sight, replacing Alfred Mann, who will assume the role of chairman emeritus.

McGuire joins Second Sight from Volcano Corp., where he was president of Americas Commercial since 2014 and senior vice president and general manager of coronary imaging, systems and program management since 2013. Prior to joining Volcano, he served as vice president and general manager of patient monitoring at Covidien. He previously served as president and chief executive officer of AtheroMed, prior to which he was chief operating officer at Spectranetics Corp. In addition, McGuire has held various positions at Guidant Corp. from 1998 to 2005.